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Abstract
Background:  The association between maternal age and risk of Down syndrome has been
repeatedly shown in various populations. However, the effect of paternal age and education of
parents has not been frequently studied. Comparative studies on Down syndrome are also rare.
This study evaluates the epidemiological characteristics of Down syndrome in two culturally and
socially contrasting population settings, in California and the Czech Republic.
Methods: The observed live birth prevalence of Down syndrome was studied among all newborns
in the California counties monitored by California Birth Defects Monitoring Program from 1996 to
1997, and in the whole Czech Republic from 1994 to 1998. Logistic regression was used to analyze
the data.
Results: A total of 516,745 (California) and 475,834 (the Czech Republic) infants were included in
the analysis. Among them, 593 and 251, respectively, had Down syndrome. The mean maternal age
of children with Down syndrome was 32.1 years in California and 26.9 years in the Czech Republic.
Children born to older mothers were at greater risk of Down syndrome in both populations. The
association with paternal age was mostly explained by adjusting for maternal age, but remained
significant in the Czech Republic. The association between maternal education and Down
syndrome was much stronger in California than in the Czech Republic but parental age influences
higher occurrence of Down syndrome both in California and in the Czech Republic.
Conclusion: The educational gradient in California might reflect selective impact of prenatal
diagnosis, elective termination, and acceptance of prenatal diagnostic measures in Californian
population.
Background
Down syndrome (also called trisomy 21 or trisomy of
chromosome 21), is the most common chromosome
abnormality in newborns. The disease is associated with
mental retardation, immune system disorders, autoim-
mune problems, premature aging and Alzheimer disease
at the age of 30–40 years [1,2]. The association between
maternal age and risk of having a Down syndrome preg-
nancy was first published in 1933 [3]. In 1959 the pres-
ence of an extra chromosome 21 was identified [4]. In
1966, the first chromosome analysis of amniotic fluid
cells was published [5]. The first report of the antenatal
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diagnosis of Down syndrome was published two years
later [6].
Many studies have been conducted to increase under-
standing of the Down syndrome epidemiology and its
geographic variations [7-11]. The relation of advanced
maternal age to an increased risk of Down syndrome has
been established, but the effects of other risk factors have
not been confirmed [12,13]. Given the current level of
knowledge, neither the conception of children with Down
syndrome nor their birth can be prevented but several
screening programs do exist.
Although Down syndrome affects a relatively small
number of families directly, internationally it is discussed
with millions of parents every year when they are offered
prenatal screening. This is often the first time the individ-
uals are confronted with questions about the usefulness
and value of genetic testing [14,15]. The diagnosis of
Down syndrome is made by chromosomal analysis,
which can be initiated prenatally (in the first or second tri-
mester of pregnancy) due to given risk factors for preg-
nancy, or postnatally due to the characteristic appearance
of the newborn child.
Because routine prenatal screening is based on the
assumption that it is reasonable for prospective parents to
choose to prevent a life with Down syndrome, the propor-
tion of people with Down syndrome in the future will be
based both on the development of prenatal screening and
on the personal choices of prospective parents [14-17].
In this study, we analyze the epidemiological characteris-
tics of Down syndrome in two culturally and socially con-
trasting settings, in California and the Czech Republic.
The Californian population represents an advanced dem-
ocratic society with a long tradition of positive attitudes
towards people with disabilities [18]. The second is a post-
communist society in transition, the Czech population. In
the Czech Republic, children with Down syndrome were
often referred at birth to residential institutions before
year 1989 (the "Velvet revolution"). The communist party
propaganda promoted better health through removing
people with disabilities from mainstream society. During
the past 15 years of societal transformation, negative atti-
tudes have changed. Most of the positive improvements,
social acceptance, and the quality of life of people with
disabilities have been the results of parental support. As a
result of parental support and activity, children with
Down syndrome are gradually integrated to the general
population. The same trend was recognized in the United
States, but it was 30–40 years earlier [19].
The objective of this study is to quantify the effects of dif-
ferent demographic factors on the prevalence of live births
with Down syndrome, to examine possible interactions
between them, and to compare effects of these factors in
two different populations. To do this, we used data from
a population-based registry in California, and from birth
and congenital anomalies registers in the Czech Republic.
Our main focus was on parental age and education.
Although the effect of maternal age as a risk factor for
Down syndrome is well known, the role of paternal age
and maternal education has not been clearly established.
Additionally, there have not been many epidemiological
studies assessing the association between Down syn-
drome and parental demographic factors in Central and
Eastern Europe.
Methods
Samples
Individual anonymous records of births and congenital
anomalies were collected from two populations.
The Californian sample comes from the California Birth
Defects Monitoring Program data (CBDMP), representing
all births from January 1, 1996, to December 31, 1997 in
hospitals in the California counties monitored by the reg-
istry (n = 516,745). In addition to birth data, the CBDMP,
a regional population-based registry of congenital anom-
alies, recorded information about birth defects within the
first year of life for all newborns registered by this
program.
The Czech sample includes all live births reported to the
Czech Statistical Office between January 1, 1994 and
December 31, 1998 (n = 475,834). For the purpose of this
study, birth registry data were linked to the Czech Con-
genital Anomalies Register by national personal identity
numbers. The mandatory statistical records are kept for all
children with congenital anomalies up to 15 years of age.
The birth/congenital anomalies data set was linked at the
Institute of Health Informatics and Statistics of the Czech
Ministry of Health (for research project No. 403/00/
1521). The linkage was successful for 95% of Down syn-
drome cases.
For our analysis, we used all live births with gestational
age 25 weeks or longer (25 weeks was the lowest recorded
gestational age in the Czech sample). Therefore, 2,366
Californian babies with recorded gestational age lower
than 25 weeks (including 4 Down syndrome cases) were
excluded from the analysis.
Variables
We used only variables available in both datasets. For this
reason we did not use, for example, ethnicity because this
variable is not available in the Czech register. Some varia-
bles were categorized for the purpose of the analysis.BMC Public Health 2005, 5:69 http://www.biomedcentral.com/1471-2458/5/69
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Maternal and paternal age at child birth was used as con-
tinuous or categorical variable. When used as categorical,
the age was classified into ten 3-year age groups (19 years
or below; 20–22, 23–25, 26–28, 29–31, 32–34, 35–37,
38–40, 41–43, and over 44 years). We used 10 categories
because we wanted to assess possible non-linear trends
between parental age and prevalence of Down syndrome,
and our large samples allowed the use of such number of
categories. Maternal education at the birth of child was
classified into four categories: primary, vocational, sec-
ondary and university.
Analysis
All live-born cases of Down syndrome (diagnosed either
pre- or postnatally) were used as the outcome in our anal-
ysis. The effect of parental characteristics on occurrence of
Down syndrome was quantified by logistic regression.
First, crude odds ratios were calculated for each of the
independent variables available in both datasets (mater-
nal and paternal age, education of mother, and sex of
infants). Then, all characteristics, except paternal age, were
entered into one model to assess their independent
effects, and adjusted odds ratios were calculated. Finally,
we included paternal age in the model, and fully adjusted
odds ratios were estimated.
All analyses were carried out using the SPSS (SPSS Inc,
Chicago, USA) and STATA (Stata Corp, College Station,
Texas, USA) statistical packages. The use of the data was in
accordance with the statutory obligations to protect confi-
dentiality. Individuals could not be identified from the
data provided for analysis.
Results
The crude observed live birth prevalence of Down syn-
drome in California was 11.5 per 10,000 births in 1996–
97 (Table 1). This figure represents 1 case of Down syn-
drome in every 870 live births. In the Czech Republic, the
live birth prevalence of Down syndrome was 5.3 per
10,000 live births in 1994–98 (Table 1). This figure repre-
sents 1 case of Down syndrome in every 1,900 live births.
There was a slightly higher proportion of boys with Down
syndrome in California (12.4 boys vs. 10.5 girls per
10,000 live births) and in the Czech Republic (5.9 boys vs.
4.6 girls per 10,000 live births).
In California, mean maternal age (SD) was 27.2 (6.5)
years for mothers of all children and 32.1 (7.3) years for
mothers of children with Down syndrome, whereas in the
Czech Republic, it was 25.1 (4.9) and 26.9 (6.3) years.
The maternal age difference between non-Down syn-
drome and Down syndrome children was significant in
both Californian and Czech samples (t = 18.84, p < 0.001
for California, and t = 6.11, p < 0.001 for the Czech
Republic). In California, the highest proportion of all
children was born to mothers aged 23–31, and of children
with Down syndrome to mothers aged 32–40. The live
birth prevalence rate of Down syndrome was higher
among older mothers (Table 1). In the Czech Republic the
largest proportion of newborns and newborns with Down
syndrome was among mothers aged 20–25 years. Preva-
lence rates of Down syndrome substantially increased
with increasing maternal age (Table 2). There is a large dif-
ference in proportion of Down syndrome babies born to
younger women (< 35 years); in California it was 59.5%
and in the Czech Republic 87.3% of Down syndrome
babies.
In California, mean age (SD) of fathers of all children and
children with Down syndrome was 35.4 (19.7) and 38.7
(18.6) years, whereas in the Czech Republic it was 28.2
(5.7) and 30.2 (6.9). The difference in paternal age
between non-Down syndrome and Down syndrome
babies was highly significant in both samples: t = 12.94 (P
< 0.001) in California and t = 5.04 (P < 0.001) in the
Czech Republic. In California, the highest percentage of
all newborns was among fathers 26–34 years old, while
the highest percentage of children with Down syndrome
among fathers 29–37 years old. In the Czech Republic it
was among 23–31 year olds for both all newborn babies
and babies with Down syndrome (Table 1). The propor-
tion of children with Down syndrome born to young
fathers (< 35 years) was 54% in California and 75% in the
Czech Republic.
Paternal and maternal age of children with Down syn-
drome was, however, highly correlated: more in the Czech
Republic (r = 0.75) than in California (r = 0.71) but both
were highly significant (p < 0.001). Similar correlations
were observed among non-Down syndrome children: cor-
relation between paternal and maternal age was 0.74 in
California and 0.72 in the Czech Republic. This strong
correlation creates great potential for residual confound-
ing of maternal age and the association between paternal
age and Down syndrome.
In California, the highest proportion of infants was
among mothers with secondary education (45.3% for all
newborn babies and 42.3% for babies with Down syn-
drome; Table 1), whereas in the Czech Republic, it was
among mothers with vocational education (41.9% for all
newborn babies and 43.8% for babies with Down syn-
drome). The live birth prevalence of Down syndrome was
the highest among mothers with the lowest education in
California, and with the highest education level in the
Czech Republic (Table 1). In California, the odds ratio of
having child with Down syndrome was 1.99 (95% CI
1.52–2.62) for mothers with completed primary educa-
tion compared to mothers with university education. In
the Czech Republic, it was 0.84 (0.51–1.39).BMC Public Health 2005, 5:69 http://www.biomedcentral.com/1471-2458/5/69
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Tables 2 and 3 show crude and adjusted odds ratios for
live birth prevalence of Down syndrome by the sex of
infants, education of mothers, maternal and paternal age
for both study populations. After simultaneously control-
ling for 4 covariates, the effects of maternal education and
maternal age increased in California, while in the Czech
Table 1: Numbers of newborns, children with Down syndrome, and prevalence rates of Down syndrome, California (1996–97) and the 
Czech Republic (1994–98)
California Czech Republic
All children Children with DS All children Children with DS
No. % of births No. % of births Prevalence per 
10 000
No. % of births No. % of births Prevalence per 
10 000
Sex of infants
Boy 264 321 51.2 328 55.3 12.4 244 503 51.4 144 57.4 5.9
Girl 252 408 48.8 265 44.7 10.5 231 331 48.6 107 42.6 4.6
Unknown 16 0 0 0
Education of mother
Primary 85 615 16.6 157 26.5 18.3 64 774 13.6 34 13.5 5.2
Vocational 107 633 20.8 96 16.2 8.9 199 260 41.9 110 43.8 5.5
Secondary 234 312 45.3 251 42.3 10.7 168 659 35.4 80 31.9 4.7
University 83 681 16.2 77 13.0 9.2 43 135 9.1 27 10.8 6.3
Unknown 5 504 12 6 0
Maternal age
-19 65 058 12.6 31 5.2 4.8 46 236 9.7 17 6.8 3.7
20–22 73 102 14.1 46 7.8 6.3 118 195 24.8 57 22.7 4.8
23–25 79 444 15.4 55 9.3 6.9 121 827 25.6 50 19.9 4.1
26–28 83 791 16.2 56 9.4 6.7 85 173 17.9 40 15.9 4.7
29–31 78 435 15.2 64 10.8 8.2 52 998 11.1 28 11.2 5.3
32–34 64 442 12.5 101 17.0 15.7 28 689 6.0 27 10.8 9.4
35–37 42 301 8.2 75 12.6 17.7 14 171 3.0 14 5.6 9.9
38–40 21 289 4.1 83 14.0 39.0 6 431 1.4 7 2.8 10.9
41–43 7 173 1.4 68 11.5 94.8 1 818 0.4 6 2.4 33.0
44+ 1 527 0.3 14 2.4 91.7 296 0.1 5 2.0 168.9
Unknown 183 0 0 0
Paternal age
-19 24 635 4.8 14 2.4 5.7 6 670 1.4 3 1.2 4.5
20–22 47 498 9.2 30 5.1 6.3 49 493 10.4 14 5.6 2.8
23–25 64 126 12.4 41 6.9 6.4 87 675 18.4 43 17.1 4.9
26–28 74 838 14.5 54 9.1 7.2 88 677 18.6 41 16.3 4.6
29–31 75 282 14.6 82 13.8 10.9 68 831 14.5 29 11.6 4.2
32–34 69 024 13.4 76 12.8 11.0 42 989 9.0 24 9.6 5.6
35–37 51 791 10.0 75 12.6 14.5 23 953 5.0 21 8.4 8.8
38–40 32 849 6.4 46 7.8 14.0 14 105 3.0 14 5.6 9.9
41–43 18 406 3.6 66 11.1 35.9 7 402 1.6 7 2.8 9.5
44+ 18 286 3.5 66 11.1 36.1 6 610 1.4 9 3.6 13.6
Unknown 40 010 43 79 429 46
Total 516 745 100 593 100 11.5 475 834 100 251 100 5.3BMC Public Health 2005, 5:69 http://www.biomedcentral.com/1471-2458/5/69
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Republic there was no change in the effect of maternal
education and a decrease in the effect of maternal age on
the occurrence of Down syndrome. When additionally
adjusted for paternal age (right panel in tables 2 and 3),
the effect of maternal age is slightly reduced but remains
highly significant. The effect of paternal age on live birth
prevalence of Down syndrome is less clear. When
adjusted for maternal age and education, the effect com-
pletely disappeared in California and was substantially
reduced in the Czech Republic.
Discussion
The main focus of the present study is to compare the epi-
demiological characteristics of Down syndrome in two
contrasting populations, in California and the Czech
Republic. Overall, prevalence of Down syndrome was sig-
nificantly higher in Californian population. Most chil-
dren with Down syndrome had parents younger than 35
years, however we found that the highest risk of having
child with Down syndrome is among older parents (and
particularly older mothers). We have also found that the
risk of Down syndrome associated with increasing age
increases more dramatically in California than in the
Czech Republic. The association with paternal age was
mostly explained when adjusted for maternal age. The
association between maternal education and Down syn-
drome was much stronger in California than in the Czech
Republic.
Table 2: Odds ratios (95% confidence interval) of occurrence of Down syndrome California, 1996–97
Crude 95% CI Fully adjusted* 95% CI
Lower Upper Lower Upper
Sex of infants
Boy 1 1
Girl 0.85 0.72 1.00 0.84 0.71 0.99
Education of mother
Primary 1.99 1.52 2.62 2.80 2.12 3.72
Vocational 0.97 0.72 1.31 2.24 1.62 3.10
Secondary 1.16 0.90 1.50 1.87 1.44 2.44
University 1 1
P for trend <0.001 <0.001
Maternal age
-19 1 1
20–22 1.32 0.84 2.08 1.66 0.95 2.92
23–25 1.45 0.94 2.26 2.05 1.14 3.68
26–28 1.40 0.90 2.17 2.18 1.20 3.99
29–31 1.71 1.12 2.63 2.74 1.49 5.04
32–34 3.29 2.20 4.92 5.47 3.00 9.98
35–37 3.72 2.45 5.66 6.27 3.37 11.64
38–40 8.21 5.43 12.40 12.34 6.61 23.05
41–43 20.07 13.12 30.71 28.42 14.98 53.91
44+ 19.40 10.30 36.55 27.57 12.22 62.21
Paternal age
-19 1 1
20–22 1.11 0.59 2.10 0.85 0.44 1.67
23–25 1.13 0.61 2.06 0.69 0.35 1.37
26–28 1.27 0.71 2.29 0.65 0.32 1.31
29–31 1.92 1.09 3.38 0.83 0.41 1.66
32–34 1.94 1.10 3.43 0.67 0.33 1.37
35–37 2.55 1.44 4.51 0.68 0.33 1.40
38–40 2.47 1.36 4.49 0.54 0.26 1.13
41–43 6.33 3.55 11.27 1.02 0.49 2.11
44+ 6.37 3.58 11.34 0.86 0.41 1.79
Note: * -Adjusted for all variables in the Table.BMC Public Health 2005, 5:69 http://www.biomedcentral.com/1471-2458/5/69
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The effect of maternal age shown in this study is in agree-
ment with several previous studies [7,20,21,23]. The
removal of the effect of paternal age after adjustment for
age of mother is very similar to recent analysis of Norwe-
gian data [21] which showed relatively strong effect of
paternal age almost completely explained by adjustment
for maternal age. The association between paternal age
and Down syndrome was also influenced by high propor-
tion of missing information about age of fathers (about
8% in California and 17% in the Czech population). We
looked at the association between education of mother
and maternal age and proportion of missing data on
paternal age. There was relationship between maternal
education and missing paternal data: paternal data were
available for 94% of children with university educated
mother compared to only 52% available data for children
with primary educated mothers. Paternal data were avail-
able for 87% of children with mothers aged 25–34 com-
pared to 71% of children with mothers aged 40 and more,
and 60% of children with mothers aged 19 or less.
Maternal age is, however, associated very strongly with
Down syndrome. The association seems to be non-linear
(much higher increase in prevalence of Down syndrome
in older age than in younger ages). We tested for several
polynomial functions but at the end we decided to use 3-
years age groups as the model using age as categorical var-
iable described the association between two variables the
best.
The data on demographic and social characteristics are
collected by the medical staff from medical records, iden-
Table 3: Odds ratios (95% confidence interval) of occurrence of Down syndrome Czech Republic, 1994–98
Crude 95% CI Fully adjusted* 95% CI
Lower Upper Lower Upper
Sex of infants
Boy 1 1
Girl 0.79 0.61 1.01 0.67 0.51 0.89
Education of mother
Primary 0.84 0.51 1.39 1.03 0.57 1.86
Vocational 0.88 0.58 1.34 1.06 0.66 1.70
Secondary 0.76 0.49 1.17 0.85 0.53 1.36
University 1 1
P for trend 0.98 0.44
Maternal age
-19 1 1
20–22 1.31 0.76 2.25 0.89 0.46 1.69
23–25 1.12 0.64 1.93 0.67 0.33 1.33
26–28 1.28 0.72 2.25 0.76 0.37 1.60
29–31 1.44 0.79 2.62 0.61 0.27 1.41
32–34 2.56 1.39 4.69 1.31 0.57 3.03
35–37 2.68 1.32 5.45 1.39 0.55 3.56
38–40 2.96 1.23 7.13 1.00 0.28 3.52
41–43 8.99 3.54 22.82 4.61 1.38 15.40
44+ 46.65 17.10 127.25 11.26 2.14 59.36
Paternal age
-19 1 1
20–22 0.63 0.18 2.19 0.68 0.19 2.41
23–25 1.09 0.34 3.51 1.33 0.40 4.50
26–28 1.03 0.32 3.32 1.34 0.39 4.63
29–31 0.94 0.29 3.08 1.23 0.35 4.40
32–34 1.24 0.37 4.12 1.49 0.41 5.46
35–37 1.95 0.58 6.53 1.98 0.52 7.44
38–40 2.21 0.63 7.69 2.02 0.51 7.96
41–43 2.10 0.54 8.14 1.68 0.38 7.42
44+ 3.03 0.82 11.20 2.03 0.47 8.77
Note: * -Adjusted for all variables in the Table.BMC Public Health 2005, 5:69 http://www.biomedcentral.com/1471-2458/5/69
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tification cards, or self-reported by the new mothers.
Although some misclassification of the independent vari-
ables could have occurred, it was probably small and ran-
dom. The international comparison is based on data from
two different sources. Thus, this study has the following
potential limitation: the diagnosis of Down syndrome is
slightly different in both populations. In California, Cali-
fornian Birth Defect Monitoring program collects the
information about congenital anomalies only for children
up to the age of one year; in the Czech Republic this infor-
mation is entered to the Register for all children up to 15
years of age. However, a high proportion of Down syn-
drome identification occurs in a very short period after
birth; in the Czech Republic 95% of cases are diagnosed
during the infant time period. It is not clear how this
would bias our results.
The advanced health care systems – prenatal care in Cali-
fornia and the Czech Republic provide a chance to com-
pare the epidemiology of Down syndrome between these
populations – the clinical practice is based on an
approach that combines routine offer of maternal serum
screening or amniocentesis to women with age 35 as a cut
off for this procedure, or both. In the Czech Republic, pre-
natal diagnostics of Down syndrome (DS) is based on sec-
ond trimester screening biochemical and ultrasound
methods. An efficiency of DS prenatal diagnostics is
around 66 – 67 % in the last years, that is, probably, a
maximum for these methods. In order to increase the pre-
natal screning efficiency and to move the diagnostics
towards earlier stages of pregnancy, methods of first tri-
mester screening are gradually introduced. At present, first
trimester screening is available at some prenatal dianos-
tics departments and is expected to be implemented at
other departments in early future. An increase of pre- and
postnatally diagnosed DS cases at present is caused by sev-
eral demographic and medical factors, such as by an
increase of mean maternal age in the country along with
increasing proportion of mothers 35 years of age old and
over and increased number of multiple pregnancies. The
current US prenatal testing guidelines recommend offer-
ing amniocentesis to women aged 35 years or older, or
women who have been found by serum and ultrasound
screening to be at a similarly high risk of giving birth to an
infant with DS or another chromosal abnormality [24].
Although the prenatal testing for chromosomal disorders
is of very high standards in both societies, other factors,
such as the use of prenatal diagnostic services and accessi-
bility of prenatal care may highly influence the prevalence
levels. It is clear that abortion of affected fetuses play the
important role in the occurrence of Down syndrome in
the newborns. The selective use of prenatal diagnostic test-
ing can have many implications in both comparative
settings.
In the Czech Republic, very low live birth prevalence rate
of Down syndrome (5.3 cases per 10,000 newborn
infants) and a low proportion of children with Down syn-
drome born to women after 35-years of age (about 13%)
supports consistent detection of this type of birth defect
during pregnancy (almost 1 from 6 newborns had inva-
sive diagnostic testing procedures during pregnancy, for
example in 2003 14,984 from 93,185 newborns had diag-
nostic test) and a high ratio of terminated pregnancies.
Congenital anomalies database (aggregated data by age of
mother) for years 1994–1998 shows that only 42% of
positively diagnosed Down syndromes were born. Among
DS pregnancies of mothers 19 years old or younger, 55%
children were born (and for age groups 20–22, 23–25 and
26–28 years, the proportions were 66%, 53% and 54%).
However, only 13% were born to those aged 35 years or
more [22] (+ Vladimir Gregor, personal communication).
Rates of pregnancies with Down syndrome in 1994–98
are shown in table 4. No significant differences in preva-
Table 4: Prevalence rates of pregnancies with Down syndrome (per 10000), Czech Republic (1994–98)
Age of mother 1994 1995 1996 1997 1998 Total
-19 6.26 8.45 4.90 5.74 8.25 6.70
20–22 5.36 6.16 8.14 7.66 11.01 7.36
23–25 5.62 8.13 9.15 8.90 7.35 7.80
26–28 7.60 9.27 6.23 8.14 11.82 8.69
29–31 12.96 6.68 6.80 9.60 16.35 10.57
32–34 26.79 13.14 26.73 14.56 31.52 22.66
35–37 21.02 36.90 48.87 45.26 52.05 40.93
38–40 125.28 96.85 86.68 102 92.88 101.07
41–43 306.12 187.2 305.6 292.4 400 297.03
44+ 333.33 615.4 169.5 204.1 317.5 337.84
Total 10.94 11 12.34 12.32 16.29 12.50BMC Public Health 2005, 5:69 http://www.biomedcentral.com/1471-2458/5/69
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lence of Down syndrome by maternal education in the
Czech population are consistent with the fact that prena-
tal care is offered free and on the same qualitative level to
all women.
The educational gradient found in Californian sample
might reflect selective impacts of maternity care, prenatal
diagnosis, elective termination, and acceptance of prena-
tal diagnostic measures. We tried to test whether the asso-
ciation between education and Down syndrome can be
confounded by ethnicity. When additional analysis
including ethnicity of mother was conducted (results not
presented), the association between maternal education
and prevalence of Down syndrome was reduced but
remained significant. Our assumption, that parents with
lower socio-economic status often have few options for
maternity care and little knowledge of prenatal testing is
supported by the data from the birth certificates analysis
(Table 5). The proportion of the amnio-utilization during
pregnancy increased not only with maternal age but also
with maternal education level. These results suggest that
special support before and during the pregnancy would
help to reduce social inequalities in prevalence of Down
syndrome in California.
Previous results suggest that the rate of detection of Down
syndrome may be higher in the Czech Republic than in
the United States. The evaluation of the prenatal screening
programs in Iowa and California showed that only
approximately 40 to 50% of the cases were detected [25-
27]. In the Czech Republic, 58% of pregnancies with DS
were aborted in 1994–1998.
In California, the higher live birth prevalence rate of
Down syndrome (11.5 cases per 10,000 newborn infants)
and higher proportion of children with Down syndrome
born to women older than 35 years (41%) might also
reflect different attitudes towards prenatal diagnosis and
abortion, different social and familial background and,
maybe, a much more favorable opinion towards people
with disabilities. Therefore it seems that the study results
are strongly related to regional social context and abortion
behavior.
As stated in the result section, the distribution of maternal
age in two populations is different (more advanced mater-
nal age in California). When birth prevalence rates in both
countries are standardized by age of mother, difference in
live birth prevalence of DS reduces (6.0 cases per 10,000
newborn infants in the Czech Republic and 10.0 in Cali-
fornia) however it is still relatively large. It can be seen
from table 1, that (with exception of 44+ age group), live
birth prevalence of DS is higher in California in every age
category.
At the beginning of the 1990s, the Czech Republic had
one of the highest rates of therapeutic abortions in the
world. The societal changes in the Czech Republic after
1989 have had a positive influence on the abortion situa-
tion. The abortion rate has significantly decreased and in
1994–1998 the induced abortion rate was 18.1 per 1,000
women of reproductive age (15–49). In the study period
the number of newborns with Down syndrome was lower
than the number of abortions with affected fetuses. A total
of 251 newborns with Down syndrome and 396 electively
aborted fetuses with Down syndrome were ascertained
(data from Czech Congenital Anomalies Register); 61% of
pregnancies with Down syndrome are electively aborted
[22]. Although abortion incidence is the subject of
research in the United States, nationally valid data are
available from only two sources: the federal Centers for
Disease Control and Prevention (CDC) and The Alan
Guttmacher Institute. However the CDC does not collect
abortion information from California specifically. In Cal-
ifornia, very limited statistics exist on abortion. The Alan
Guttmacher Institute estimates the induced abortion rate
was 31.2 per 1,000 women of reproductive age in Califor-
nia in 2000 [28]. Since December 2002 there have been
restrictions on abortion in California – a woman must
receive mandatory state-directed counseling before an
abortion is provided. In the 1996–1997 California
Genetic Disease Branch data set, a total of 456 positive
pregnancies with Down syndrome were diagnosed via
Table 5: Births with Amniocentesis by Mother's education and age, California, 1998 (in %)
Mother's education: Mother's age:
(in years) - 19 years 20–34 years 35 + years Total
0 – 8 years 0.3 0.4 2.0 0.6
9 – 11 years 0.3 0.5 4.0 0.6
12 – 15 years 0.5 0.9 11.1 2.2
16 + years - 1.7 16.5 6.1
Total 0.4 0.9 11.5 2.5
Source: CDC, 1998, Birth Cohort Data SetBMC Public Health 2005, 5:69 http://www.biomedcentral.com/1471-2458/5/69
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amniocenteses and 267 from them were electively
aborted; the termination rate for these pregnancies was
58.5% (information obtained from the Department of
Health Services, Genetic Disease Branch, Richmond,
USA).
It is clearly recognized that Down syndrome prenatal
screening is driven by several primary forces: (i) effort to
reduce "the costs of life-long care" of people with Down
syndrome through prenatal screening; (ii) clinical support
for individual choices of mothers or couples; (iii) public
health strategies designed to reduce birth defects and
improving reproductive outcomes [14].
The social benefits of prenatal screening of Down syn-
drome are very important: (i) the prospective parents
demand to be well-informed about their pregnancy out-
comes, and (ii) the prospective parents need time to make
informed decisions about selective prenatal termination
of affected pregnancies or follow-up with it. When the
pregnancy for Down syndrome affected child continues,
the main goal is to support socially disadvantaged fami-
lies, and to help to start lives of children born with Down
syndrome.
Conclusion
This study supports previous research showing that most
children with Down syndrome are born to parents below
35 years of age and that significant risk levels for Down
syndrome are not only in advanced maternal age catego-
ries. However risk of births with Down syndrome signifi-
cantly increases with increasing paternal age, and, in
particular, with increasing maternal age. Additionally,
educational effects on maternal age-specific risk rates of
Down syndrome were found for California mothers. The
educational gradient might reflect selective impacts of
maternity care, prenatal diagnosis, elective termination,
and acceptance of prenatal diagnostic measures in the
Californian population. On average, parents with lower
socio-economic status often have few options for mater-
nity care and little knowledge of prenatal testing, and they
need special support for their start with parenthood and
well-being of future generations. To prevent births of
unwanted children with Down syndrome, comprehensive
maternity care services must be available to all pregnant
women regardless of socio-economic status. Prenatal
diagnostic testing is also important for pregnant women
at any age who would not consider abortion because
babies with Down syndrome can need specialized care at
delivery. Individuals with Down syndrome can live full,
productive, and quality lives with help from modern med-
icine and lifetime educational/support programs. Access
to the prenatal testing of chromosomal disorders to all
pregnant women may be one possible task in strategy to
reduce social inequalities in health.
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